Cargando…

Nonlinear relationship between serum total bilirubin levels and initial ischemic stroke in patients with non-valvular atrial fibrillation

OBJECTIVE: This study aimed to examine the relationship between total bilirubin levels and initial ischemic stroke in patients with non-valvular atrial fibrillation. METHODS: This was a retrospective study. Atrial fibrillation was diagnosed by 24-hour Holter electrocardiography and serum total bilir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ying, Wang, Jie, Zeng, Wen-zhen, Lyu, Qing-shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Retrospective Clinical Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645432/ https://www.ncbi.nlm.nih.gov/pubmed/33100092 http://dx.doi.org/10.1177/0300060520962347

Ejemplares similares

Total Bilirubin Level is Associated with the Risk of Left Atrial Appendage Thrombosis in Patients with Non-Valvular Atrial Fibrillation
por: Meng, Weihao, et al.
Publicado: (2022)

A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation
por: Shang, Luxiang, et al.
Publicado: (2021)

The Relationship Between Serum Bilirubin Concentration and Atrial Fibrillation
por: Demir, Mehmet, et al.
Publicado: (2013)

Stroke Prevention in Atrial Fibrillation and Valvular Heart Disease
por: Ahmad, Saad, et al.
Publicado: (2016)

Role of hyperhomocysteine, thyroid dysfunction and their interaction in ischemic stroke patients with non-valvular atrial fibrillation
por: Wang, Lili, et al.
Publicado: (2020)

Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation have a Risk for Aortogenic Embolizations
por: Kojima, Keisuke, et al.
Publicado: (2021)

Complex Aortic Arch Atherosclerosis in Acute Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation
por: Suzuki, Masayuki, et al.
Publicado: (2021)

Effect of advanced age on plasma homocysteine levels and its association with ischemic stroke in non-valvular atrial fibrillation
por: Yao, Yan, et al.
Publicado: (2017)

Metabolomic and Proteomic Analyses of Persistent Valvular Atrial Fibrillation and Non-Valvular Atrial Fibrillation
por: Hu, Bo, et al.
Publicado: (2021)

Response to “Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation have a Risk for Aortogenic Embolizations”
por: Suzuki, Masayuki, et al.
Publicado: (2021)

Ischemic stroke risk factors not included in the CHADS-VASC score in patients with non-valvular atrial fibrillation
por: Le Goff, Laurine, et al.
Publicado: (2023)

Persistent or permanent atrial fibrillation is associated with severe cardioembolic stroke in patients with non-valvular atrial fibrillation
por: Hagii, Joji, et al.
Publicado: (2021)

Risk factors for ischemic stroke in patients with non-valvular atrial fibrillation and therapeutic international normalized ratio range
por: Wańkowicz, Paweł, et al.
Publicado: (2018)

Mendelian Randomization to Evaluate the Causal Effect of Serum Bilirubin on Atrial Fibrillation
por: Hisamatsu, Takashi
Publicado: (2023)

Practical Issues to Prevent Stroke Associated with Non-valvular Atrial Fibrillation
por: Kim, Chi Kyung, et al.
Publicado: (2013)

Decreased Serum Total Bilirubin Level Predicts Early Neurological Deterioration in Patients with Acute Ischemic Stroke
por: Sheng, Xihua, et al.
Publicado: (2021)

Infarct Volumes of Patients with Acute Ischemic Stroke Receiving Direct Oral Anticoagulants due to Non-Valvular Atrial Fibrillation
por: Yavasoglu, Nese G., et al.
Publicado: (2021)

Ischemic Stroke and Systemic Embolism Among One-and-Done Direct Oral Anticoagulant Users with Non-valvular Atrial Fibrillation
por: Alberts, Mark, et al.
Publicado: (2023)

Ischemic stroke as the initial manifestation of atrial fibrillation; is it higher than expected?
por: Sadeghi Hokmabadi, Elyar, et al.
Publicado: (2021)

Association Between Serum Bilirubin and Atrial Fibrillation: A Mendelian Randomization Study
por: Kim, Si-Woo, et al.
Publicado: (2023)

Economic Evaluation of Apixaban for the Prevention of Stroke in Non-Valvular Atrial Fibrillation in the Netherlands
por: Stevanović, Jelena, et al.
Publicado: (2014)

Characteristics of Pulmonary Vein Enlargement in Non-Valvular Atrial Fibrillation Patients with Stroke
por: Lee, Jung Myung, et al.
Publicado: (2014)

A Study of Cardiogenic Stroke Risk in Non-valvular Atrial Fibrillation Patients
por: Song, Ziliang, et al.
Publicado: (2020)

Relationship between valvular structure and biochemical indices of non-valvular atrial fibrillation and senile degenerative valvular heart disease
por: Chen, Jian-Qin, et al.
Publicado: (2023)

Novel prognostic score based on the preoperative total bilirubin-albumin ratio and fibrinogen-albumin ratio in ampullary adenocarcinoma
por: Zhang, Xiao-Jie, et al.
Publicado: (2023)

Decreased serum bilirubin levels in children with lead poisoning
por: Ye, Mengsi, et al.
Publicado: (2021)

Newer Anticoagulants for Non-Valvular Atrial Fibrillation
por: Harburger, Joseph M., et al.
Publicado: (2012)

Early Administration of Edoxaban After Acute Ischemic Stroke in Patients With Non-valvular Atrial Fibrillation: A Pilot Randomized Trial
por: Kim, Jong S., et al.
Publicado: (2023)

Differentiation of Atrial Fibrillation and Atrial Fibrillation-Associated Ischemic Stroke Based on Serum Exosome miRNA-Seq
por: Xie, Yun, et al.
Publicado: (2023)

Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
por: Samaras, Athanasios, et al.
Publicado: (2021)

Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation
por: Hamatani, Yasuhiro, et al.
Publicado: (2016)

Modification of the left atrial appendage and its role in stroke risk reduction with non-valvular atrial fibrillation
por: Rashid, Hashrul N., et al.
Publicado: (2020)

Value of pretransplant albumin-bilirubin score in predicting outcomes after liver transplantation
por: Ma, Tao, et al.
Publicado: (2019)

Trials of Novel Oral Anticoagulants for Stroke Prevention In Patients with Non-valvular Atrial Fibrillation
por: Halperin, Jonathan L, et al.
Publicado: (2014)

Sex Differences in Outcomes among Stroke Survivors with Non-Valvular Atrial Fibrillation in China
por: Hong, Yan, et al.
Publicado: (2017)

Cost-effectiveness of apixaban for stroke prevention in non-valvular atrial fibrillation in Saudi Arabia
por: Hersi, Ahmad S., et al.
Publicado: (2019)

Economic and Clinical Impact of Stroke and Warfarin Use for Patients with Non-valvular Atrial Fibrillation
por: Wang, Li, et al.
Publicado: (2013)

Prior ischemic strokes are non-inferior for predicting future ischemic strokes than CHA(2)DS(2)-VASc score in hemodialysis patients with non-valvular atrial fibrillation
por: Bel-Ange, Anat, et al.
Publicado: (2021)

Treatment standards for direct oral anticoagulants in patients with acute ischemic stroke and non-valvular atrial fibrillation: A survey among German stroke units
por: Fastner, Christian, et al.
Publicado: (2022)

Ischemic stroke, hemorrhage, and mortality in patients with non-valvular atrial fibrillation and renal dysfunction treated with rivaroxaban: sub-analysis of the EXPAND study
por: Atarashi, Hirotsugu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q2pnnt8tufrkp57m6ogo52dsgo